Peter Christian Warnke to Glioblastoma
This is a "connection" page, showing publications Peter Christian Warnke has written about Glioblastoma.
Regional cerebral blood flow in peritumoral brain edema during dexamethasone treatment: a xenon-enhanced computed tomographic study. Neurosurgery. 1998 Aug; 43(2):235-40; discussion 240-1.
Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1995 Apr; 36(4):872-4.
Response to Drs. Simpson, et al.: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group clinical trials. Int J Radiat Oncol Biol Phys. 1994 Apr 30; 29(1):220.
Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene--a phase I/II clinical protocol. J Neurooncol. 2003 Aug-Sep; 64(1-2):147-54.
Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. J Mol Med (Berl). 1997 Apr; 75(4):300-4.
The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery. 1994 Aug; 35(2):344-5.
Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg. 1993 May; 78(5):762-6.
[The value of stereotactic biopsy and percutaneous radiation in therapy of glioblastoma multiforme]. Nervenarzt. 1992 Aug; 63(8):480-4.